These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
48. Characterization of metabotropic glutamate receptor-mediated facilitation of N-methyl-D-aspartate depolarization of neocortical neurones. Rahman S; Neuman RS Br J Pharmacol; 1996 Feb; 117(4):675-83. PubMed ID: 8646413 [TBL] [Abstract][Full Text] [Related]
49. AMPA receptor agonists: resolution, configurational assignment, and pharmacology of (+)-(S)- and (-)-(R)-2-amino-3-[3-hydroxy-5-(2-pyridyl)-isoxazol-4-yl]-propionic acid (2-Py-AMPA). Johansen TN; Ebert B; Falch E; Krogsgaard-Larsen P Chirality; 1997; 9(3):274-80. PubMed ID: 9176992 [TBL] [Abstract][Full Text] [Related]
50. Interference of S-nitrosoglutathione with the binding of ligands to ionotropic glutamate receptors in pig cerebral cortical synaptic membranes. Hermann A; Varga V; Janáky R; Dohovics R; Saransaari P; Oja SS Neurochem Res; 2000 Aug; 25(8):1119-24. PubMed ID: 11055750 [TBL] [Abstract][Full Text] [Related]
51. Computer imaging and analysis of dopamine (D2) and serotonin (S2) binding sites in rat basal ganglia or neocortex labeled by [3H]spiroperidol. Altar CA; Kim H; Marshall JF J Pharmacol Exp Ther; 1985 May; 233(2):527-38. PubMed ID: 3889277 [TBL] [Abstract][Full Text] [Related]
52. Synthesis, pharmacological characterization, and molecular modeling of heterobicyclic amino acids related to (+)-2-aminobicyclo[3.1.0] hexane-2,6-dicarboxylic acid (LY354740): identification of two new potent, selective, and systemically active agonists for group II metabotropic glutamate receptors. Monn JA; Valli MJ; Massey SM; Hansen MM; Kress TJ; Wepsiec JP; Harkness AR; Grutsch JL; Wright RA; Johnson BG; Andis SL; Kingston A; Tomlinson R; Lewis R; Griffey KR; Tizzano JP; Schoepp DD J Med Chem; 1999 Mar; 42(6):1027-40. PubMed ID: 10090786 [TBL] [Abstract][Full Text] [Related]
54. Effects of acromelic acid A on the binding of [3H]-kainic acid and [3H]-AMPA to rat brain synaptic plasma membranes. Smith AL; McIlhinney RA Br J Pharmacol; 1992 Jan; 105(1):83-6. PubMed ID: 1375859 [TBL] [Abstract][Full Text] [Related]
55. Resolution, absolute stereochemistry, and pharmacology of the S-(+)- and R-(-)-isomers of the apparent partial AMPA receptor agonist (R,S)-2-amino-3-(3-hydroxy-5-phenylisoxazol-4-yl)propionic acid [(R,S)-APPA]. Ebert B; Lenz S; Brehm L; Bregnedal P; Hansen JJ; Frederiksen K; Bøgesø KP; Krogsgaard-Larsen P J Med Chem; 1994 Apr; 37(7):878-84. PubMed ID: 7512140 [TBL] [Abstract][Full Text] [Related]
56. Up-regulation of cortical AMPA receptor binding in the fawn-hooded rat following ethanol withdrawal. Chen F; Jarrott B; Lawrence AJ Eur J Pharmacol; 1999 Nov; 384(2-3):139-46. PubMed ID: 10611433 [TBL] [Abstract][Full Text] [Related]
57. Regional variations in the pharmacology of AMPA receptors as revealed by receptor autoradiography. Porter RH; Greenamyre JT Brain Res; 1994 Nov; 664(1-2):202-6. PubMed ID: 7534602 [TBL] [Abstract][Full Text] [Related]
59. Changes in [3H]AMPA and [3H]kainate binding in rat caudate-putamen and nucleus accumbens after 6-hydroxydopamine lesions of the medial forebrain bundle: an autoradiographic study. Zavitsanou K; Mitsacos A; Giompres P; Kouvelas ED Brain Res; 1996 Aug; 731(1-2):132-40. PubMed ID: 8883863 [TBL] [Abstract][Full Text] [Related]
60. Kainate binding to the AMPA receptor in rat brain. Hall RA; Kessler M; Lynch G Neurochem Res; 1994 Jun; 19(6):777-82. PubMed ID: 7520541 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]